Last updated on November 2017

A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults with Moderate to Severe Binge Eating Disorder


Brief description of study

A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults with Moderate to Severe Binge Eating Disorder

Detailed Study Description

This study is already listed... the sponsor must have added it. We want to make it more specific to our site... with the Volunteer/Contact information..

Clinical Study Identifier: TX12342

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lynn Badgett, R.N., B.S.N., C.C.R.C.

Pharmacology Research Institute, Encino
Encino, CA USA
  Connect »

My-Linh Tong, R.N., M.S.N., N.P.

Pharmacology Research Institute, Newport Beach
Newport Beach, CA USA
  Connect »

Coastal Carolina Research Center

Coastal Carolina Research Center
Mount Pleasant, SC USA
  Connect »